Abstract
Lymphangioleiomyomatosis (LAM) is a rare hamartomatous proliferation of smooth muscle in the lungs, mediastinum, and abdomen. [1] [2] [3] [4] [5] In the lungs the abnormal proliferation of smooth muscle is seen around airways, blood vessels, and lymphatics. It extends into the alveolar interstitium causing cystic change and into pulmonary veins causing lung haemorrhage. Lymph node involvement leads to chylous eVusion. 2 It aVects women of reproductive age and is characterised by dyspnoea, recurrent pneumothorax, chylothorax, and haemoptysis. Chest radiographs show diVuse interstitial infiltrates and cysts of uniform size. Pulmonary function tests often show airflow limitation with an increase in residual volume. Pulmonary LAM occurs alone or associated with tuberous sclerosis. It is thought that pulmonary LAM is a forme fruste of tuberous sclerosis. 6 It usually progresses to death from respiratory insuYciency. LAM was first reported in Korea in 1984, since when a total of 18 Korean cases have been published, including one in a man. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] To understand the clinical characteristics of LAM better we reviewed the published Korean cases together with five previously unreported patients from our own institute.
Methods
The records of 10 cases of pulmonary LAM (including five cases published previously) were retrieved from our institute (Seoul National University Hospital) together with 13 other Korean cases from a review of the literature. The pathological specimens of seven of these 23 patients were reviewed at the Asian Congress on Lymphangioleiomyomatosis held in Kyoto, Japan in February 1993. 4 During that meeting two cases-the first to be reported from Korea 7 and a man 8 -were excluded after reviewing the pathology. For this study we included only the remaining 21 cases, all of which were proven pathologically by open lung biopsy (19 cases), video-assisted thoracoscopic lung biopsy (one case), or examination of lung resected at transplantation (one case). We reviewed the clinical, radiological, and pathological findings. To correlate the clinical and radiological findings, pulmonary function tests were compared with disease severity based on observation by HRCT scanning. The severity of disease based on the HRCT scan was defined by dividing each patient's lung into three zones: upper, middle, and lower. The size of the cysts was then scored from 1 to 4 in each lung zone with 1 = cysts of <0.5 cm diameter, 2 = 0.5-1 cm, 3 = 1-2 cm, and 4 = >2 cm. The amount of cystic change as a proportion of cystic change in each lung zone was also scored from 1 to 4 with 1 = change of <25%, 2 = 25-50%, 3 = 51-75%, and 4 = >75%. The summation of the size score and the proportion score in every zone of the lung was used to quantify the disease severity on the HRCT scan. The relationship between disease severity on the HRCT scan and the results of pulmonary function tests was examined.
Results

CLINICAL FEATURES
The clinical features of the 21 cases of LAM are summarised in table 1. The age at onset of symptoms ranged from 20 to 48 years with a mean (SD) age of 32 (8.6) years. All the patients were women. The main clinical manifestations at presentation or during follow up were dyspnoea (19 patients), spontaneous pneumothorax (13 patients), chest pain (6 patients), haemoptysis (4 patients), and cough (4 patients). No patients had chylothorax or chylous ascites. Three patients had episodes of pneumothorax during pregnancy (cases 7, 17, and 19) and case 7 had two abortions, one spontaneous and the other artificial after pneumothorax. In one patient the dyspnoea was more severe during clomiphene therapy given to induce ovulation (case 15). Six cases were accompanied by other features of tuberous sclerosis. One had only a renal angiomyolipoma (case 4), but cases 8, 12, 14, 18, and 21 had many other features of tuberous sclerosis such as facial angiofibroma, ungual fibroma, or subependymal nodule.
PULMONARY FUNCTION TESTS
The pulmonary function tests (table 2) showed an increase in the ratio of residual volume (RV) to total lung capacity (TLC) but a decrease occurred in the ratio of forced expiratory volume in one second (FEV 1 ) to forced vital capacity (FVC) and in the carbon monoxide transfer factor (TLCO).
RADIOLOGICAL FINDINGS
In all cases the simple chest radiograph showed diVuse reticulonodular or reticular infiltration that was more marked in the lower lung zones ( fig 1A) . Other findings included pneumothorax (10 patients), cystic lesions (three patients), hyperinflation (six patients), and pleural eVusion (one patient, case 13). HRCT scans showed thin walled cysts throughout the whole lung zones ( fig 1B) . Severity scores based on HRCT findings of cases 1-5 were 18, 20, 16, 21, and 8, respectively. The overall severity score correlated with the percentage of measured carbon monoxide transfer factor (TLCO) per alveolar volume (VA) to predicted value (r = -0.90, p = 0.03) and FEV 1 /FVC (r = -0.95, p = 0.02). There was no significant correlation with the other pulmonary function test results. Case 5 had serial CT scans available. No diVerence was noted between two CT scans and her symptoms were also unchanged over this period.
PATHOLOGICAL FINDINGS
All 21 patients were proved pathologically to have LAM. The diagnostic features were nodular proliferation of smooth muscle cells, dilated pulmonary lymphatic vessels, and the formation of air cysts. The smooth muscle nodules were in the wall of the aVected lymphatic vessels and cellularity was higher in †Age at onset means the age at the onset of symptoms, but where the age is in parentheses this is the age on her first visit to the physician. ‡They were erroneously diagnosed as miliary tuberculosis at first. §Number in parentheses following pneumothorax indicates frequency of pneumothorax. {She had concurrent pulmonary tuberculosis and was given anti-tuberculous medications.
¶She underwent bilateral sequential lung transplantation. those nodules than in those in the bronchial smooth muscle. Cystic changes in the lung were not associated with pulmonary parenchymal fibrosis nor with activation of alveolar epithelial cells. Some cases (cases 1, 4 and 17) showed papilliferous proliferation of smooth muscle nodules, protruding into the lumen. Other cases (cases 2, 3 and 5) had small slender smooth muscle bundles in the vicinity of the lung cysts. Receptor assay using immunohistochemistry could be performed in seven cases: the oestrogen receptor was negative in all seven cases while the progesterone receptor was positive in three out of five cases.
TREATMENT AND OUTCOME All patients were treated with medroxyprogesterone and/or tamoxifen. No patient underwent oophorectomy. Pleurodesis was performed in the cases with recurrent pneumothorax. One patient underwent lung transplantation. It was possible to evaluate the outcomes in 10 cases followed up for at least 12 months (table 3) . In eight of the 10 cases (80%) the disease progressed and three eventually died, two from respiratory insuYciency and one from infection after lung transplantation (case 8).
Discussion
LAM is a progressive and generally fatal disease that aVects women of childbearing age. 4 was a clinicopathological study and included five of the 21 cases included in this paper. We can therefore confirm that pulmonary LAM occurs exclusively in women.
The Korean cases do not diVer very greatly in their clinical, functional, radiological or pathological features or in their outcome from those reported elsewhere, except that no Korean patients have experienced chylothorax or chylous ascites. The radiographic abnormalities observed were similar to those already reported, consisting of interstitial infiltrates and thin walled cysts. On simple chest radiography the infiltrates were more marked in the lower lung zones, but the cystic change identified on the CT scans showed no remarkable diVerences between upper, middle and lower lung zones except in case 5 where the upper lung zones were less severely aVected. However, in case 2 there were larger cysts in the upper zone than in the lower lung zones. This patient suVered from frequent pneumothoraces. The overall severity score based on HRCT scans correlated with the percentage predicted TLCO/VA (p = 0.03) and FEV 1 /FVC (p = 0.02), but not with FEV 1 . From these observations it appears that functional impairment is worse when the cysts are larger and more numerous. It was not possible to determine whether small cysts become larger as the disease progresses because serial follow up CT scans were not available.
In reviewing the pathological findings of six cases we found a variable degree of pulmonary destruction but the overall degree of pulmonary parenchymal damage could not be assessed because the biopsy samples were too small. We could not find any relationship between the pathological findings and the clinical course of the disease. The pathological status of the other 15 patients could not be reviewed as their data were collected retrospectively.
Because LAM is a rare disease, true examples of which have only been reported since 1990 in Korea, and pulmonary tuberculosis is still prevalent in our country, 22 some physicians erroneously diagnose pulmonary LAM as miliary tuberculosis (see cases 1 and 14) . In Korea the diVerential diagnosis between the two should therefore be kept in mind. DiVerences include fever and miliary rather than reticulonodular density in miliary tuberculosis. However, concurrent pulmonary tuberculosis and LAM were detected in one case (case 5).
One patient (case 15) suVered increasing dyspnoea during treatment with clomiphene, a feature of LAM that has not previously been reported. This might be a chance finding in a patient who was at the right age to be taking clomiphene or it might be that clomiphene, which has both oestrogenic and antioestrogenic properties, 23 24 may aggravate LAM.
All the Korean patients were treated with medroxyprogesterone and/or tamoxifen but, apart from two patients who stabilised, all the others whose outcome could be evaluated progressed despite treatment. No patient underwent oophorectomy. Lung transplantation can be valuable for patients with end stage lymphangioleiomyomatosis 25 but the only Korean patient who underwent lung transplantation died of post-transplantation infection.
